title: The molecular basis for neuroimmune receptor signaling.
abstract: Many of the receptors which are responsible for the responses to the common drugs of abuse belong to the G protein-coupled receptor (GPCR) family. In this special issue of the Journal of Neuroimmune Pharmacology a collection of papers is presented which deals with signaling events that are important for the function of these receptors. Because these receptors are expressed by both neuronal and immune cells, and because these receptors play a complex role in regulating function in both the nervous and immune systems, a more complete understanding of the regulation of expression of these receptors is essential. Moreover, once these receptors are expressed and activated, a complex series of signaling events are initiated that can have substantial significance. We have only a limited understanding of these signaling events, but with more complete information, we may be able to control the undesirable and/or desirable consequences of receptor activation by drugs of abuse.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Rogers
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology*; D063386:Cannabinoid Receptor Agonists / Q000494:pharmacology*; D063385:Cannabinoid Receptor Modulators / Q000494:pharmacology*; D002186:Cannabinoids / Q000494:pharmacology*; D054377:Chemokine CXCL12 / Q000502:physiology*; D013759:Dronabinol / Q000494:pharmacology*; D063388:Endocannabinoids / Q000494:pharmacology*; D005260:Female; D015699:HIV Envelope Protein gp120 / Q000633:toxicity*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D008213:Lymphocyte Activation / Q000502:physiology*; D008214:Lymphocytes / Q000502:physiology*; D035683:MicroRNAs / Q000502:physiology*; D009020:Morphine / Q000633:toxicity*; D009294:Narcotics / Q000633:toxicity*; D017072:Neostriatum / Q000166:cytology*; D009420:Nervous System / Q000254:growth & development*; D009474:Neurons / Q000473:pathology*; D053284:Polyunsaturated Alkamides / Q000494:pharmacology*; D011247:Pregnancy; D043884:Receptor, Cannabinoid, CB1 / Q000187:drug effects*; D043885:Receptor, Cannabinoid, CB2 / Q000187:drug effects*; D043882:Receptors, Cannabinoid; D043562:Receptors, G-Protein-Coupled / Q000187:drug effects* / Q000502:physiology*; D017450:Receptors, Opioid, mu / Q000096:biosynthesis* / Q000187:drug effects*; D015398:Signal Transduction / Q000502:physiology*; D013601:T-Lymphocytes / Q000502:physiology*; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects*; D000095383:Trace Amine-Associated Receptors
chemical_list: D000701:Analgesics, Opioid; D001095:Arachidonic Acids; D063386:Cannabinoid Receptor Agonists; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D054377:Chemokine CXCL12; D013759:Dronabinol; D063388:Endocannabinoids; D015699:HIV Envelope Protein gp120; D035683:MicroRNAs; D009020:Morphine; D009294:Narcotics; D053284:Polyunsaturated Alkamides; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D043882:Receptors, Cannabinoid; D043562:Receptors, G-Protein-Coupled; D017450:Receptors, Opioid, mu; D000095383:Trace Amine-Associated Receptors; C524885:GPR55 protein, human; C456739:virodhamine; C078814:anandamide